Your browser doesn't support javascript.
loading
Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial.
McClung, M R; Lewiecki, E M; Geller, M L; Bolognese, M A; Peacock, M; Weinstein, R L; Ding, B; Rockabrand, E; Wagman, R B; Miller, P D.
Affiliation
  • McClung MR; Oregon Osteoporosis Center, 5050 NE Hoyt Street, Suite 626, Portland, OR 97213, USA. mmcclung@orost.com
Osteoporos Int ; 24(1): 227-35, 2013 Jan.
Article in En | MEDLINE | ID: mdl-22776860
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Density / Osteoporosis, Postmenopausal / Bone Remodeling / Bone Density Conservation Agents / Antibodies, Monoclonal, Humanized Type of study: Clinical_trials Limits: Aged / Female / Humans / Middle aged Language: En Journal: Osteoporos Int Journal subject: METABOLISMO / ORTOPEDIA Year: 2013 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Density / Osteoporosis, Postmenopausal / Bone Remodeling / Bone Density Conservation Agents / Antibodies, Monoclonal, Humanized Type of study: Clinical_trials Limits: Aged / Female / Humans / Middle aged Language: En Journal: Osteoporos Int Journal subject: METABOLISMO / ORTOPEDIA Year: 2013 Document type: Article Affiliation country: Country of publication: